The startup Hippocratic AI, which focuses on developing AI solutions for non-diagnostic tasks in patient interaction, has secured a significant Series B funding round of $141 million, valuing the company at $1.64 billion.
This funding comes just nine months after Hippocratic AI raised $53 million from General Catalyst and Andreessen Horowitz and five months after securing $17 million from Nvidia. Remarkably, the startup has been operational for less than two years.
Unlike many companies in the generative AI healthcare space that focus on reducing administrative burdens, Hippocratic AI is tackling the issue of medical professional shortages. The startup is developing agents capable of handling straightforward tasks such as conducting preoperative procedures, remote patient monitoring, and preparation for medical appointments.
In 2024, the company signed contracts with 23 healthcare systems and insurance companies. The funds raised will be used to expand the product into new markets, including international ones.
